CLDX Quote, Trading Chart, Celldex Therapeutics Inc.
home / stock / cldx / cldx quote
$25.20 Last:
-4.98% Change Percent:
$25.69 Open:
$25.20 Previous Close:
$26.64 High:
$24.18 Low:
640,162 Volume:
03/04/2021 04:55:23 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-03-04 | 25.69 | 25.2 | 26.64 | 24.18 | 640,162 |
| 2021-03-03 | 29.9 | 26.52 | 29.94 | 26.51 | 457,881 |
| 2021-03-02 | 28.63 | 29.91 | 30.17 | 28.5 | 397,238 |
| 2021-03-01 | 27.44 | 28.19 | 28.5 | 27.44 | 423,923 |
| 2021-02-26 | 27.58 | 27.08 | 28.02 | 26.46 | 423,450 |
| 2021-02-25 | 27.98 | 27.51 | 28.79 | 27.04 | 678,306 |
| 2021-02-24 | 27.59 | 27.75 | 28.05 | 26.795 | 581,984 |
| 2021-02-23 | 28.71 | 27.71 | 28.71 | 25.84 | 821,369 |
| 2021-02-22 | 27.73 | 28.25 | 29.3 | 26.48 | 895,954 |
| 2021-02-19 | 27.25 | 27.89 | 28.12 | 26.92 | 575,140 |
| 2021-02-18 | 25.56 | 26.65 | 26.71 | 25.07 | 851,892 |
| 2021-02-17 | 24.89 | 25.6 | 26.07 | 24.505 | 950,818 |
| 2021-02-16 | 24.69 | 25.25 | 25.37 | 24.06 | 733,673 |
| 2021-02-15 | 23.5 | 24.3 | 24.96 | 23.3 | 448,878 |
| 2021-02-12 | 23.5 | 24.3 | 24.96 | 23.3 | 448,767 |
| 2021-02-11 | 23.19 | 23.75 | 24.16 | 22.75 | 455,627 |
| 2021-02-10 | 22.55 | 22.82 | 23.4 | 21.975 | 469,173 |
| 2021-02-09 | 24.35 | 22.5 | 24.54 | 22.34 | 529,653 |
| 2021-02-08 | 24.02 | 24.21 | 25.73 | 23.84 | 689,979 |
| 2021-02-05 | 23.755 | 23.8 | 24.48 | 23.11 | 461,092 |
Celldex Therapeutics Inc. Company Name:
CLDX Stock Symbol:
NASDAQ Market:
Celldex Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
--Dermatological indication characterized by chronic, intensely itchy nodules; mast cell activation believed to play an important role in amplifying chronic itch and neuroinflammation-- --Potential to expand future CDX-0159 development beyond chronic urticarias to chronic pruritic d...
-
HAMPTON, N.J., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) today announced that the Company will participate in a fireside chat at the 10th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 24, 2021 at 2:20 p.m. ET. A webcast of the ...
-
Celldex Therapeutics (CLDX) has developed CDX-0159, an anti-C-KIT antibody that has blockbuster potential in various mast cell diseases, explains biotech expert Jay Silverman, contributing editor to The Medical Technology Stock Letter. For further details see: Top Picks 2021- Celldex Th...